エル・ティー・エスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/06/15 | 3,695 | 3,695 | 3,470 | 3,470 | -230 | -6.2% | 31,900 |
2022/06/14 | 3,490 | 3,700 | 3,490 | 3,700 | +150 | +4.2% | 28,100 |
2022/06/13 | 3,465 | 3,560 | 3,400 | 3,550 | +35 | +1% | 16,900 |
2022/06/10 | 3,555 | 3,565 | 3,480 | 3,515 | -110 | -3% | 20,200 |
2022/06/09 | 3,530 | 3,655 | 3,485 | 3,625 | +95 | +2.7% | 30,700 |
2022/06/08 | 3,330 | 3,530 | 3,330 | 3,530 | +220 | +6.6% | 28,700 |
2022/06/07 | 3,435 | 3,435 | 3,310 | 3,310 | -130 | -3.8% | 25,500 |
2022/06/06 | 3,530 | 3,530 | 3,440 | 3,440 | -125 | -3.5% | 19,300 |
2022/06/03 | 3,560 | 3,685 | 3,560 | 3,565 | ±0 | ±0% | 25,700 |
2022/06/02 | 3,730 | 3,730 | 3,560 | 3,565 | -180 | -4.8% | 32,700 |
2022/06/01 | 3,840 | 3,855 | 3,735 | 3,745 | -95 | -2.5% | 21,200 |
2022/05/31 | 3,800 | 3,860 | 3,720 | 3,840 | +10 | +0.3% | 27,000 |
2022/05/30 | 3,680 | 3,840 | 3,675 | 3,830 | +195 | +5.4% | 36,600 |
2022/05/27 | 3,835 | 3,845 | 3,625 | 3,635 | -225 | -5.8% | 48,200 |
2022/05/26 | 3,725 | 3,865 | 3,725 | 3,860 | +135 | +3.6% | 41,300 |
2022/05/25 | 3,800 | 3,860 | 3,655 | 3,725 | -25 | -0.7% | 42,400 |
2022/05/24 | 3,735 | 3,785 | 3,665 | 3,750 | -50 | -1.3% | 43,400 |
2022/05/23 | 3,680 | 3,815 | 3,660 | 3,800 | +165 | +4.5% | 81,700 |
2022/05/20 | 3,410 | 3,645 | 3,410 | 3,635 | +185 | +5.4% | 74,500 |
2022/05/19 | 3,315 | 3,470 | 3,260 | 3,450 | +65 | +1.9% | 52,800 |
2022/05/18 | 3,335 | 3,450 | 3,300 | 3,385 | +65 | +2% | 58,700 |
2022/05/17 | 3,290 | 3,415 | 3,205 | 3,320 | +70 | +2.2% | 99,000 |
2022/05/16 | 2,913 | 3,250 | 2,913 | 3,250 | +501 | +18.2% | 137,500 |
2022/05/13 | 2,621 | 2,813 | 2,621 | 2,749 | +142 | +5.4% | 29,600 |
2022/05/12 | 2,656 | 2,702 | 2,565 | 2,607 | -99 | -3.7% | 27,400 |
2022/05/11 | 2,671 | 2,734 | 2,653 | 2,706 | ±0 | ±0% | 17,200 |
2022/05/10 | 2,663 | 2,732 | 2,582 | 2,706 | -57 | -2.1% | 35,800 |
2022/05/09 | 2,906 | 2,906 | 2,735 | 2,763 | -163 | -5.6% | 26,300 |
2022/05/06 | 2,840 | 2,949 | 2,801 | 2,926 | +86 | +3% | 21,700 |
2022/05/02 | 2,829 | 2,851 | 2,798 | 2,840 | +15 | +0.5% | 16,200 |
2022/04/28 | 2,842 | 2,845 | 2,797 | 2,825 | -51 | -1.8% | 16,000 |
2022/04/27 | 2,813 | 2,876 | 2,762 | 2,876 | -22 | -0.8% | 28,100 |
2022/04/26 | 2,782 | 2,898 | 2,782 | 2,898 | +142 | +5.2% | 16,500 |
2022/04/25 | 2,700 | 2,784 | 2,653 | 2,756 | -17 | -0.6% | 25,000 |
2022/04/22 | 2,800 | 2,800 | 2,726 | 2,773 | -67 | -2.4% | 15,900 |
2022/04/21 | 2,733 | 2,855 | 2,715 | 2,840 | +102 | +3.7% | 27,000 |
2022/04/20 | 2,903 | 2,905 | 2,718 | 2,738 | -165 | -5.7% | 27,600 |
2022/04/19 | 2,930 | 2,942 | 2,852 | 2,903 | -27 | -0.9% | 16,900 |
2022/04/18 | 2,887 | 2,940 | 2,872 | 2,930 | +13 | +0.4% | 18,100 |
2022/04/15 | 2,919 | 2,954 | 2,857 | 2,917 | -16 | -0.5% | 15,200 |
2022/04/14 | 2,967 | 3,040 | 2,930 | 2,933 | -34 | -1.1% | 8,200 |
2022/04/13 | 2,861 | 2,978 | 2,861 | 2,967 | +81 | +2.8% | 29,200 |
2022/04/12 | 2,902 | 2,974 | 2,874 | 2,886 | -61 | -2.1% | 27,300 |
2022/04/11 | 3,000 | 3,040 | 2,895 | 2,947 | -88 | -2.9% | 31,300 |
2022/04/08 | 2,959 | 3,035 | 2,914 | 3,035 | +115 | +3.9% | 26,200 |
2022/04/07 | 2,936 | 2,967 | 2,860 | 2,920 | -53 | -1.8% | 30,400 |
2022/04/06 | 2,901 | 3,000 | 2,889 | 2,973 | -19 | -0.6% | 28,400 |
2022/04/05 | 3,040 | 3,100 | 2,980 | 2,992 | -13 | -0.4% | 34,700 |
2022/04/04 | 2,874 | 3,030 | 2,874 | 3,005 | +139 | +4.8% | 37,800 |
2022/04/01 | 2,897 | 2,919 | 2,828 | 2,866 | -62 | -2.1% | 28,400 |
601~
650
件表示中 / 1694件
類似銘柄と比較する
現在ご覧いただいている「LTS」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
LTS | 230,600円 | +34.8% | +52.7% | 1.30% | 10.71倍 | 2.74倍 |
|
ビジネスプロセス可視化・改善・実行支援など展開、ITビジネスマッチング「アサインナビ」も |
メドピア | 49,100円 | -17.1% | -35.1% | 0.92% | 21.33倍 | 1.13倍 |
|
医師向け情報サイト運営、製薬会社の広告料が収益源。法人向け医療相談や特定保健指導も展開 |
FCE | 97,200円 | +14.9% | +29.6% | 1.44% | 16.86倍 | 3.15倍 |
|
業務改善用RPAソフトでDX支援。クラウドサービスでeラーニング展開。配当性向25%目安 |
MDNT | 4,000円 | +21.1% | - | 0.00% | - | 2.04倍 |
|
東大医科研発。がん免疫細胞療法の細胞加工が核。医薬品開発、医薬品受託製造(CDMO)も |
ZETA | 40,900円 | -54.0% | - | 1.71% | 282.07倍 | 7.62倍 |
|
ZETAを子会社化しビッグデータ活用の推奨商品表示(CX改善)が柱に。ネット広告は撤退 |
市場注目の銘柄
チャート関連のコラム